Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This is a pre-surgical study involving subjects with local advanced bladder cancer, who are
candidates for neoadjuvant therapy. It is a single-arm phase II portion.